Brief: Kadimastem - Total Proceeds From Equity Financing Reach $3 Million
30/06/2025 12:24
June 30 (Reuters) - Kadimastem Ltd KDST.TA: KADIMASTEM LTD - TOTAL PROCEEDS FROM EQUITY FINANCING REACH $3 MILLION KADIMASTEM LTD - FUNDS TO SUPPORT PENDING MERGER WITH KADIMASTEM Source text: ID:nPn5Crz2Za Further company coverage: KDST.TA (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on NewcelX AG
See all newsBrief: Newcelx Announces Pricing Of $1.4 Million Equity Financing At 20% Premium Pricing
Brief: Newcelx Submits Pre-IND Package To FDA For NCEL-101 For Treatment Of Type 1 Diabetes
Brief: Newcelx Updates Corporate Presentation To Highlight Type 1 Diabetes Flagship Program
U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences
U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing